Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
批准号:
9896734
负责人:
Gianfranco D Alpini
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-10-01 至 2022-03-31
关键词:
AddressAnimal ModelAnimalsApplications GrantsAttenuatedBiliaryCholestasisChronicCirrhosisCollagenDataDevelopmentExhibitsFatty LiverFibronectinsFibrosisGrowthHealthHepatic Stellate CellHepatobiliaryHigh Fat DietHumanImpairmentIn VitroInjuryIntestinal AbsorptionIntestinesIntrahepatic bile ductKnockout MiceLinkLipidsLiverLiver FibrosisLiver diseasesLoxP-flanked alleleMediatingMusNerve Growth FactorsNeurosecretory SystemsNonesterified Fatty AcidsObesityPPAR alphaPathogenesisPathway interactionsPatientsPhenotypePlayPublic HealthRegulationResistanceRoleSamplingSecretinSignal TransductionSmooth Muscle Actin Staining MethodSteatohepatitisTLR4 geneTestingTransforming Growth FactorsUnited States Department of Veterans AffairsVEGFA geneVascular Endothelial Growth FactorsWestern Worldabsorptionautocrinebasebile ductcholangiocytecholestatic liver diseasechronic liver diseaseeffective therapyinsightknock-downlipid metabolismliver injurymouse modelnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovelnovel therapeutic interventionparacrineresponsesecretin receptor
中文摘要
非酒精性脂肪性肝病(NAFLD)是一个令人担忧的公共卫生问题,目前被认为是最严重的
西方世界常见的肝病。非酒精性脂肪肝患者可能发展为非酒精性脂肪性肝炎
(NASH),其中许多人发生肝损伤,可能进展为肝硬变。我们之前已经展示了
在慢性淤胆性肝病中,胆管细胞通过其细胞激活的产物
如分泌素(SCT),是胆管损伤和上皮下纤维化之间的关键环节。
是慢性肝胆损伤的特征。我们还证明了SCT/SR轴的激活
在胆汁淤积的动物模型中,在肝纤维化和胆管损伤的进展中起关键作用
和人肝标本通过胆管细胞分泌转化生长因子-β1(TGF-β1)和
随后激活肝星状细胞(HSCs)。最近的证据和我们新的初步数据
提示胆管细胞在NAFLD/NASH的发病机制中起关键作用。
胆管损伤/增殖和随后的肝纤维化。我们的初步数据显示,SCT/分泌素
NAFLD/NASH和人肝胆管细胞受体(SR)轴上调
脂肪变性和脂肪性肝炎的样本支持SCT/SR轴在
NAFLD和NASH的进展。基于这些发现,我们提出了中心假设,即
SCT/SR轴信号转导通路在介导增殖和活化的促纤维化胆管表型中的关键作用
这在肝脂肪变性和肝纤维化的发病机制中起着重要作用。
NAFLD/NASH。为了验证我们的假设,我们提出了两个具体的目标:(I)激活SCT/SR轴
刺激神经内分泌/促纤维化胆管表型对FFA诱导的胆管损伤的反应
通过旁分泌的转化生长因子-β1依赖的机制触发肝星状细胞的激活;以及(Ii)抑制
NAFLD/NASH进展过程中的表型和肝脏脂肪变性及纤维化。已完成的
拟议的研究将提供SCT/SR轴激活如何促进的翻译机制
局部和全身反应介导神经内分泌/促纤维生成胆管表型和
NAFLD/NASH进展过程中的肝胆脂肪变性和纤维化。
英文摘要
Nonalcoholic fatty liver disease (NAFLD) is an alarming public health concern and now considered the most
common liver disease in the Western world. Patients with NAFLD may develop nonalcoholic steatohepatitis
(NASH) of which many develop hepatic injury that may progress to cirrhosis. We have previously shown
that in chronic cholestatic liver diseases, cholangiocytes, through the products of their cellular activation
such as secretin (SCT), are the key link between bile duct injury and the subepithelial fibrosis that
characterizes chronic hepatobiliary injury. We have also demonstrated that activation of the SCT/SR axis
plays a key role in the progression of liver fibrosis and biliary damage during cholestasis in animal models
and human liver samples via secretion of transforming growth factor-b1 (TGF-b1) by cholangiocytes and
subsequent activation of hepatic stellate cells (HSCs). Recent evidence and our novel preliminary data
indicate that cholangiocytes play a key role in the pathogenesis of NAFLD/NASH through activation of
biliary damage/proliferation and subsequent liver fibrosis. Our preliminary data that the SCT/secretin
receptor (SR) axis is upregulated in cholangiocytes in an animal model of NAFLD/NASH and human liver
samples with steatosis and steatohepatitis support the concept that the SCT/SR axis plays a key role in the
progression of NAFLD and NASH. Based upon these findings, we propose the central hypothesis that the
SCT/SR axis signaling is key for mediating the proliferative and activated profibrogenic biliary phenotype
that contributes to the progression of hepatic steatosis and fibrosis during the pathogenesis of
NAFLD/NASH. To test our hypothesis, two Specific Aims are proposed: (i) activation of the SCT/SR axis
stimulates a neuroendocrine/profibrogenic biliary phenotype in response to FFA-induced biliary damage
triggering the activation of HSCs via a paracrine TGF-b1-dependent mechanism; and (ii) inhibition of the
SCT/SR axis and downstream pathways attenuates the activated neuroendocrine/profibrogenic biliary
phenotype and hepatic steatosis and fibrosis during the progression of NAFLD/NASH. Completion of the
proposed studies will provide a translational mechanism of how activation of the SCT/SR axis promotes
local and systemic responses to mediate activation of neuroendocrine/profibrogenic biliary phenotype and
hepatobiliary steatosis and fibrosis during the progression of NAFLD/NASH.!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Ductular Reaction by Substance P during Alcohol-induced Liver Injury
-
批准号:10592570
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2023
-
负责人:Gianfranco D Alpini
-
依托单位:
Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity
-
批准号:10467095
-
项目类别:
-
资助金额:$56.71万
-
财政年份:2022
-
负责人:Gianfranco D Alpini
-
依托单位:
Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity
-
批准号:10596643
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2022
-
负责人:Gianfranco D Alpini
-
依托单位:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
-
批准号:10252062
-
项目类别:
-
资助金额:$54.05万
-
财政年份:2020
-
负责人:Gianfranco D Alpini
-
依托单位:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
-
批准号:10457005
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2020
-
负责人:Gianfranco D Alpini
-
依托单位:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
-
批准号:10676118
-
项目类别:
-
资助金额:$53.64万
-
财政年份:2020
-
负责人:Gianfranco D Alpini
-
依托单位:
ShEEP Request for Leica Laser Capture Microdissection System (LMD7)
-
批准号:9908938
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10618284
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:9763814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
The Role of Stem Cell Derived Microvesicles in Cholestatic Liver Injury
-
批准号:9930828
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:9912633
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10454226
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10265373
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Gianfranco D Alpini
-
依托单位:
Neuroendocrine Regulation of Biliary Growth and Fibrosis
-
批准号:9310481
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2017
-
负责人:Gianfranco D Alpini
-
依托单位:
Regulation of cellular senescence by non-coding RNAs in alcoholic liver injury
-
批准号:9564772
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2017
-
负责人:Gianfranco D Alpini
-
依托单位:
The Role of Stem Cell Derived Microvesicles in Cholestatic Liver Injury
-
批准号:9086358
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2015
-
负责人:Gianfranco D Alpini
-
依托单位:
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
-
批准号:10565852
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gianfranco D Alpini
-
依托单位:
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
-
批准号:8195932
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gianfranco D Alpini
-
依托单位:
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
-
批准号:7797746
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gianfranco D Alpini
-
依托单位:
Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth
-
批准号:8397529
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gianfranco D Alpini
-
依托单位:
海外基金